CRIS
Curis, Inc.NASDAQHealthcare$0.55-3.07%ClosedMarket Cap: $7.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
12.85
P/S
0.74
EV/EBITDA
-0.11
DCF Value
$-0.36
FCF Yield
-387.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.5%
Operating Margin
-348.4%
Net Margin
-80.3%
ROE
101.7%
ROA
-38.0%
ROIC
-696.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.1M | 100.0% | $-7.6M | $19.4M | $1.23 | — |
| FY 2025 | $9.4M | 99.5% | $-32.9M | $-7.6M | $-0.58 | — |
| Q3 2025 | $3.2M | 99.5% | $-6.9M | $-7.7M | $-0.49 | — |
| Q2 2025 | $2.7M | 99.4% | $-8.3M | $-8.6M | $-0.68 | — |
| Q1 2025 | $2.4M | 99.4% | $-10.2M | $-10.6M | $-1.25 | — |
| Q4 2024 | $3.3M | 99.5% | $-9.0M | $-9.6M | $-1.25 | — |
| FY 2024 | $10.9M | 99.1% | $-44.5M | $-43.4M | $-6.88 | — |
| Q3 2024 | $2.9M | 99.2% | $-10.6M | $-10.1M | $-1.70 | — |
| Q2 2024 | $2.5M | 99.5% | $-12.5M | $-11.8M | $-2.03 | — |
| Q1 2024 | $2.1M | 97.7% | $-12.5M | $-11.9M | $-2.05 | — |
| Q4 2023 | $2.7M | 98.0% | $-12.2M | $-11.7M | $-2.04 | — |
| FY 2023 | $10.0M | 97.9% | $-48.3M | $-47.4M | $-8.96 | — |